Ready for ctDNA-guided treatment decisions in colorectal cancer?  

作　　者：Jiaolin Zhou Guole Lin 

机构地区：[1]Department of General Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China

出　　处：《Journal of the National Cancer Center》2023年第1期1-3,共3页癌症科学进展（英文）

摘　　要：With the improved detection sensitivity and diagnostic accuracy,circulating tumor DNA(ctDNA)has emerged as a highly valuable biomarker in precision oncology for colorectal cancer(CRC).ctDNA has been well established as a strong prognostic indicator in predicting re-currence after radical surgery of CRC.

关 键 词：COLORECTAL CTDNA SURGERY 

分 类 号：R73[医药卫生—肿瘤]